Saturday, 5 September 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· July 11, 2026

Nancy Pelosi, Donald Trump Bet On The Same 10 Stocks – Some Might Surprise You (CORRECTED)

View original at finance.yahoo.com
Nancy Pelosi, Donald Trump Bet On The Same 10 Stocks – Some Might Surprise You (CORRECTED) Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Trump has made 19 transactions in Uber stock in 2026, with the largest transaction a $1 million to $5 million purchase in March 2026.

    60% confidence

  • Trump's trades are said to be managed by a blind trust.

    60% confidence

  • Benzinga's Government Trades page for Pelosi shows 10 stocks disclosed by the congresswoman in the past five years that have not been sold, and were also bought by Trump in 2026.

    60% confidence

Data points we hold from this source

Donald Trump · transaction count20 transactions
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com
Nancy Pelosi, Donald Trump Bet On The Same 10 Stocks – Some Might Surprise You (CORRECTED) — Source | Via News | ViaNews EU